Heron Therapeutics, Inc. (HRTX)
USD 1.87
(-10.95%)
USD 1.87
(-10.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 61.93 Million USD | 17.31% |
| 2022 | 52.79 Million USD | 30.93% |
| 2021 | 40.32 Million USD | -23.12% |
| 2020 | 52.44 Million USD | -37.82% |
| 2019 | 84.34 Million USD | 68.83% |
| 2018 | 49.96 Million USD | 90.85% |
| 2017 | 26.17 Million USD | 2004.42% |
| 2016 | 1.24 Million USD | 269.48% |
| 2015 | -734 Thousand USD | 98.66% |
| 2014 | -54.83 Million USD | -77.36% |
| 2013 | -30.91 Million USD | -119.65% |
| 2012 | -14.07 Million USD | -2278.79% |
| 2011 | 646 Thousand USD | -50.35% |
| 2010 | 1.3 Million USD | 3.17% |
| 2009 | 1.26 Million USD | 241.73% |
| 2008 | 369 Thousand USD | -10.44% |
| 2007 | 412 Thousand USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 5.39 Million USD | -0.24% |
| 2004 | 5.4 Million USD | 11.47% |
| 2003 | 4.84 Million USD | -9.72% |
| 2002 | 5.37 Million USD | 36.05% |
| 2001 | 3.94 Million USD | 43.39% |
| 2000 | 2.75 Million USD | -80.34% |
| 1999 | 14 Million USD | -2.1% |
| 1998 | 14.3 Million USD | 16.26% |
| 1997 | 12.3 Million USD | 32.26% |
| 1996 | 9.3 Million USD | 47.62% |
| 1995 | 6.3 Million USD | -8.7% |
| 1994 | 6.9 Million USD | -16.87% |
| 1993 | 8.3 Million USD | 137.14% |
| 1992 | 3.5 Million USD | 105.88% |
| 1991 | 1.7 Million USD | 41.67% |
| 1990 | 1.2 Million USD | -42.86% |
| 1989 | 2.1 Million USD | 10.53% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 26.22 Million USD | 7.71% |
| 2024 Q2 | 25.5 Million USD | -2.75% |
| 2023 Q3 | 13.22 Million USD | 13.98% |
| 2023 Q4 | 24.34 Million USD | 84.09% |
| 2023 Q2 | 11.6 Million USD | -9.07% |
| 2023 FY | 61.93 Million USD | 17.31% |
| 2023 Q1 | 12.76 Million USD | -26.67% |
| 2022 FY | 52.79 Million USD | 30.93% |
| 2022 Q1 | 12.1 Million USD | 24.58% |
| 2022 Q2 | 11.45 Million USD | -5.35% |
| 2022 Q3 | 11.84 Million USD | 3.36% |
| 2022 Q4 | 17.4 Million USD | 46.97% |
| 2021 Q2 | 7.92 Million USD | -26.73% |
| 2021 Q1 | 10.81 Million USD | -3.59% |
| 2021 Q3 | 11.87 Million USD | 49.97% |
| 2021 Q4 | 9.71 Million USD | -18.23% |
| 2021 FY | 40.32 Million USD | -23.12% |
| 2020 Q4 | 11.21 Million USD | -12.36% |
| 2020 Q3 | 12.79 Million USD | -6.35% |
| 2020 FY | 52.44 Million USD | -37.82% |
| 2020 Q1 | 14.77 Million USD | -23.07% |
| 2020 Q2 | 13.66 Million USD | -7.54% |
| 2019 Q3 | 25.42 Million USD | 10.22% |
| 2019 Q2 | 23.07 Million USD | 38.65% |
| 2019 Q1 | 16.64 Million USD | -3.66% |
| 2019 FY | 84.34 Million USD | 68.83% |
| 2019 Q4 | 19.2 Million USD | -24.46% |
| 2018 Q4 | 17.27 Million USD | 41.46% |
| 2018 Q2 | 12.04 Million USD | 42.83% |
| 2018 FY | 49.96 Million USD | 90.85% |
| 2018 Q1 | 8.43 Million USD | -3.22% |
| 2018 Q3 | 12.21 Million USD | 1.36% |
| 2017 Q4 | 8.71 Million USD | 15.88% |
| 2017 Q1 | 2.44 Million USD | 96.62% |
| 2017 Q2 | 7.49 Million USD | 206.5% |
| 2017 FY | 26.17 Million USD | 2004.42% |
| 2017 Q3 | 7.52 Million USD | 0.32% |
| 2016 Q3 | -29.58 Million USD | -8.41% |
| 2016 FY | 1.24 Million USD | 269.48% |
| 2016 Q1 | -16.09 Million USD | 1.05% |
| 2016 Q4 | 1.24 Million USD | 104.21% |
| 2016 Q2 | -27.28 Million USD | -69.56% |
| 2015 Q4 | -16.26 Million USD | -14.2% |
| 2015 FY | -734 Thousand USD | 98.66% |
| 2015 Q2 | -16.17 Million USD | -11.52% |
| 2015 Q1 | -14.5 Million USD | -16.23% |
| 2015 Q3 | -14.24 Million USD | 11.96% |
| 2014 FY | -54.83 Million USD | -77.36% |
| 2014 Q4 | -12.47 Million USD | 15.29% |
| 2014 Q3 | -14.73 Million USD | -3.17% |
| 2014 Q2 | -14.27 Million USD | -22.8% |
| 2014 Q1 | -11.62 Million USD | -72.16% |
| 2013 FY | -30.91 Million USD | -119.65% |
| 2013 Q1 | -7.14 Million USD | -38.59% |
| 2013 Q4 | -6.75 Million USD | -8.66% |
| 2013 Q2 | -10.8 Million USD | -51.34% |
| 2013 Q3 | -6.21 Million USD | 42.48% |
| 2012 Q4 | -5.15 Million USD | -42.08% |
| 2012 FY | -14.07 Million USD | -2278.79% |
| 2012 Q3 | -3.62 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q1 | 395 Thousand USD | 120.67% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q2 | 251 Thousand USD | -36.46% |
| 2011 Q3 | - USD | -100.0% |
| 2011 FY | 646 Thousand USD | -50.35% |
| 2010 Q1 | 241 Thousand USD | 97.54% |
| 2010 Q2 | 530 Thousand USD | 119.92% |
| 2010 Q3 | 351 Thousand USD | -33.77% |
| 2010 Q4 | 179 Thousand USD | -49.0% |
| 2010 FY | 1.3 Million USD | 3.17% |
| 2009 Q1 | 8000.00 USD | -61.9% |
| 2009 Q3 | 1.11 Million USD | 7878.57% |
| 2009 Q4 | 122 Thousand USD | -89.08% |
| 2009 FY | 1.26 Million USD | 241.73% |
| 2009 Q2 | 14 Thousand USD | 75.0% |
| 2008 Q4 | 21 Thousand USD | -67.19% |
| 2008 Q1 | 133 Thousand USD | 0.76% |
| 2008 Q2 | 152 Thousand USD | 14.29% |
| 2008 FY | 369 Thousand USD | -10.44% |
| 2008 Q3 | 64 Thousand USD | -57.89% |
| 2007 Q2 | 160 Thousand USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | 121 Thousand USD | -24.38% |
| 2007 FY | 412 Thousand USD | 0.0% |
| 2007 Q4 | 132 Thousand USD | 9.09% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 Q2 | 1.25 Million USD | -8.09% |
| 2005 Q4 | 1.44 Million USD | 8.0% |
| 2005 Q3 | 1.33 Million USD | 6.96% |
| 2005 FY | 5.39 Million USD | -0.24% |
| 2005 Q1 | 1.36 Million USD | -8.23% |
| 2004 FY | 5.4 Million USD | 11.47% |
| 2004 Q1 | 1.18 Million USD | -13.11% |
| 2004 Q4 | 1.48 Million USD | 1.65% |
| 2004 Q3 | 1.45 Million USD | 13.55% |
| 2004 Q2 | 1.28 Million USD | 8.81% |
| 2003 FY | 4.84 Million USD | -9.72% |
| 2003 Q3 | 1.26 Million USD | 13.52% |
| 2003 Q4 | 1.35 Million USD | 7.1% |
| 2003 Q2 | 1.11 Million USD | 0.99% |
| 2003 Q1 | 1.1 Million USD | -40.92% |
| 2002 Q3 | 1.23 Million USD | 8.15% |
| 2002 FY | 5.37 Million USD | 36.05% |
| 2002 Q4 | 1.87 Million USD | 51.7% |
| 2002 Q1 | 1.12 Million USD | -13.66% |
| 2002 Q2 | 1.14 Million USD | 1.54% |
| 2001 Q4 | 1.3 Million USD | 47.67% |
| 2001 FY | 3.94 Million USD | 43.39% |
| 2001 Q1 | 877.41 Thousand USD | 53.68% |
| 2001 Q2 | 886.89 Thousand USD | 1.08% |
| 2001 Q3 | 881.28 Thousand USD | -0.63% |
| 2000 FY | 2.75 Million USD | -80.34% |
| 2000 Q3 | 769.93 Thousand USD | 4.45% |
| 2000 Q2 | 737.15 Thousand USD | -66.28% |
| 2000 Q4 | 570.93 Thousand USD | -25.85% |
| 2000 Q1 | 2.18 Million USD | -68.32% |
| 1999 Q1 | 3.4 Million USD | -19.05% |
| 1999 FY | 14 Million USD | -2.1% |
| 1999 Q3 | 3.3 Million USD | 3.13% |
| 1999 Q2 | 3.2 Million USD | -5.88% |
| 1999 Q4 | 6.9 Million USD | 109.09% |
| 1998 Q1 | 3.2 Million USD | 3.23% |
| 1998 FY | 14.3 Million USD | 16.26% |
| 1998 Q2 | 3.5 Million USD | 9.38% |
| 1998 Q4 | 4.2 Million USD | 20.0% |
| 1998 Q3 | 3.5 Million USD | 0.0% |
| 1997 FY | 12.3 Million USD | 32.26% |
| 1997 Q2 | 2.7 Million USD | -28.95% |
| 1997 Q4 | 3.1 Million USD | 24.0% |
| 1997 Q3 | 2.5 Million USD | -7.41% |
| 1997 Q1 | 3.8 Million USD | 137.5% |
| 1996 FY | 9.3 Million USD | 47.62% |
| 1996 Q1 | 2.3 Million USD | 187.5% |
| 1996 Q3 | 2.6 Million USD | -7.14% |
| 1996 Q2 | 2.8 Million USD | 21.74% |
| 1996 Q4 | 1.6 Million USD | -38.46% |
| 1995 Q2 | 1.7 Million USD | -29.17% |
| 1995 Q4 | 800 Thousand USD | -46.67% |
| 1995 Q3 | 1.5 Million USD | -11.76% |
| 1995 FY | 6.3 Million USD | -8.7% |
| 1995 Q1 | 2.4 Million USD | 0.0% |
| 1994 Q2 | 1.6 Million USD | -15.79% |
| 1994 Q1 | 1.9 Million USD | -17.39% |
| 1994 FY | 6.9 Million USD | -16.87% |
| 1994 Q3 | 900 Thousand USD | -43.75% |
| 1994 Q4 | 2.4 Million USD | 166.67% |
| 1993 Q3 | 1.8 Million USD | -5.26% |
| 1993 FY | 8.3 Million USD | 137.14% |
| 1993 Q4 | 2.3 Million USD | 27.78% |
| 1993 Q1 | 1.2 Million USD | 140.0% |
| 1993 Q2 | 1.9 Million USD | 58.33% |
| 1992 Q1 | 200 Thousand USD | 100.0% |
| 1992 FY | 3.5 Million USD | 105.88% |
| 1992 Q3 | 1.2 Million USD | -20.0% |
| 1992 Q4 | 500 Thousand USD | -58.33% |
| 1992 Q2 | 1.5 Million USD | 650.0% |
| 1991 FY | 1.7 Million USD | 41.67% |
| 1991 Q4 | 100 Thousand USD | -50.0% |
| 1991 Q1 | 200 Thousand USD | -33.33% |
| 1991 Q2 | 1.2 Million USD | 500.0% |
| 1991 Q3 | 200 Thousand USD | -83.33% |
| 1990 FY | 1.2 Million USD | -42.86% |
| 1990 Q1 | 300 Thousand USD | 0.0% |
| 1990 Q3 | 200 Thousand USD | -60.0% |
| 1990 Q4 | 300 Thousand USD | 50.0% |
| 1990 Q2 | 500 Thousand USD | 66.67% |
| 1989 Q1 | 500 Thousand USD | 0.0% |
| 1989 Q3 | 400 Thousand USD | -66.67% |
| 1989 Q4 | 300 Thousand USD | -25.0% |
| 1989 FY | 2.1 Million USD | 10.53% |
| 1989 Q2 | 1.2 Million USD | 140.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -62.89% |
| Alkermes plc | 1.37 Billion USD | 95.494% |
| Agenus Inc. | 139.61 Million USD | 55.636% |
| Aptorum Group Limited | -1.11 Million USD | 5656.622% |
| Ardelyx, Inc. | 106.66 Million USD | 41.929% |
| Dyadic International, Inc. | 922.95 Thousand USD | -6610.93% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -194.093% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 35525.496% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 563.69% |
| Novavax, Inc. | 639.93 Million USD | 90.321% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 232.238% |
| Pyxis Oncology, Inc. | -2 Million USD | 3196.95% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 12086.353% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -225.259% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 140271.54% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 11853.131% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 163.063% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -7623.067% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 75635.366% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 54.21% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -686.927% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 163.888% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 95.919% |
| AlloVir, Inc. | -398 Thousand USD | 15662.563% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 74.271% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -14508.255% |
| Bicycle Therapeutics plc | -129.52 Million USD | 147.822% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -51515.833% |
| ChromaDex Corporation | 50.78 Million USD | -21.975% |
| Chimerix, Inc. | 324 Thousand USD | -19016.975% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 298.728% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 179.82% |
| CRISPR Therapeutics AG | 240.95 Million USD | 74.294% |
| Precision BioSciences, Inc. | 40.47 Million USD | -53.042% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 163.098% |
| Fortress Biotech, Inc. | 57.85 Million USD | -7.063% |
| Fortress Biotech, Inc. | 57.85 Million USD | -7.063% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -273.644% |
| ImmuCell Corporation | 4.39 Million USD | -1308.894% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 158.365% |
| Immix Biopharma, Inc. | -5468.00 USD | 1132854.206% |
| Incyte Corporation | 3.44 Billion USD | 98.2% |
| Innoviva, Inc. | 261.06 Million USD | 76.274% |
| IO Biotech, Inc. | -756 Thousand USD | 8292.989% |
| Jaguar Health, Inc. | 7.72 Million USD | -701.903% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 9428.163% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 48.278% |
| ContextLogic Inc. | 59 Million USD | -4.981% |
| MiMedx Group, Inc. | 266.84 Million USD | 76.788% |
| MEI Pharma, Inc. | 49.32 Million USD | -25.568% |
| NextCure, Inc. | -3.68 Million USD | 1781.298% |
| Onconetix, Inc. | -1.12 Million USD | 5595.114% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 313.819% |
| Opthea Limited | 21.72 Thousand USD | -285070.35% |
| Psyence Biomedical Ltd. | -240.00 USD | 25808016.667% |
| Vaxcyte, Inc. | -75 Million USD | 182.585% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 108146.959% |
| Precigen, Inc. | 106 Thousand USD | -58333.019% |
| Pharming Group N.V. | 220.1 Million USD | 71.859% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -11926.99% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -6038.652% |
| PureTech Health plc | -1.6 Million USD | 3963.943% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 43.575% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 134.143% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 236.655% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 381.707% |
| Acelyrin, Inc. | -115 Thousand USD | 53960.0% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 616347.14% |
| Summit Therapeutics Inc. | -2.05 Million USD | 3121.415% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 10947.461% |
| Senti Biosciences, Inc. | -2.68 Million USD | 2408.572% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1428.98% |
| Elevation Oncology, Inc. | -39 Thousand USD | 158917.949% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1390.934% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1671.239% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -112.637% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -12387.702% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 112716.364% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 40.5% |
| Seer, Inc. | 7.02 Million USD | -781.443% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1314.778% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -187.487% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 52373.168% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 43323.006% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -10070.608% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 48.587% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 80.254% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1238880.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -2306.333% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 122171.344% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -110.77% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 26797.845% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 12689.228% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 972.626% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 13152.292% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 595667.308% |
| Soligenix, Inc. | 97.31 Thousand USD | -63550.564% |
| Century Therapeutics, Inc. | -10.8 Million USD | 673.032% |
| Kura Oncology, Inc. | -849 Thousand USD | 7395.524% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 192.303% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 42235.374% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 37.46% |
| Autolus Therapeutics plc | -4.86 Million USD | 1372.632% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -49.662% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 36968.452% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 34.61% |
| GRI Bio, Inc. | 10.84 Million USD | -471.34% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -2338.557% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 813.008% |
| IGM Biosciences, Inc. | -211.66 Million USD | 129.263% |
| INmune Bio, Inc. | 155 Thousand USD | -39860.645% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 4212.021% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 9651.796% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 211683.658% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -15307.711% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 3203.156% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 19888.818% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 34.429% |
| Verastem, Inc. | -62 Thousand USD | 100001.613% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -2443.696% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 23831.418% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -1946.217% |
| Histogen Inc. | 3.76 Million USD | -1543.38% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -10649.958% |
| Surrozen, Inc. | -27.23 Million USD | 327.466% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1249.36% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 5240.678% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 341.506% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -208.892% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 3128332.323% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -921.014% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 92365.868% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 59.985% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -42382.167% |
| Apollomics, Inc. | 127 Thousand USD | -48670.866% |
| Amarin Corporation plc | 165.54 Million USD | 62.584% |
| Mesoblast Limited | -9.81 Million USD | 731.065% |
| Turnstone Biologics Corp. | 16.5 Million USD | -275.251% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 156.059% |
| Synaptogenix, Inc. | -6347.00 USD | 975978.368% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 121549.02% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 61.616% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 96.476% |
| Better Therapeutics, Inc. | -2.72 Million USD | 2369.659% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 155.223% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 81.679% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 543043.548% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1089.441% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 5690.162% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -746.392% |
| Insmed Incorporated | 239.63 Million USD | 74.153% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -1631.107% |
| OmniAb, Inc. | 14.66 Million USD | -322.302% |
| Alector, Inc. | -95.05 Million USD | 165.163% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 50.694% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 242.51% |
| Zai Lab Limited | 170.9 Million USD | 63.758% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 24.351% |
| Aura Biosciences, Inc. | -1.29 Million USD | 4882.934% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -47545.385% |
| Immunic, Inc. | -111 Thousand USD | 55900.901% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -290.684% |
| Veracyte, Inc. | 248.14 Million USD | 75.039% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.886% |
| FibroGen, Inc. | 128.9 Million USD | 51.95% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 10982192.199% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 630.896% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 98.178% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -15822.622% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 82.569% |
| TG Therapeutics, Inc. | 219.1 Million USD | 71.731% |
| Galecto, Inc. | -830 Thousand USD | 7562.53% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 4572.13% |
| Fortrea Holdings Inc. | 424 Million USD | 85.392% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 171.883% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 11023.986% |
| XBiotech Inc. | -1.74 Million USD | 3651.548% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 5690.162% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 233.285% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 182.001% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 15.618% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -268.619% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 84.079% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 224.759% |
| Vaxxinity, Inc. | -2.23 Million USD | 2872.56% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 81.044% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 646.979% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -153.319% |
| NexImmune, Inc. | -1.02 Million USD | 6142.994% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1146918.519% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 971.686% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.452% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 92785.591% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 1844.269% |
| Ainos, Inc. | -253.73 Thousand USD | 24511.094% |
| Pluri Inc. | 322 Thousand USD | -19135.714% |
| Prothena Corporation plc | -129.2 Million USD | 147.94% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -22.836% |
| Celularity Inc. | 6.75 Million USD | -816.936% |
| Rallybio Corporation | -150 Thousand USD | 41392.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 289.956% |
| MeiraGTx Holdings plc | 287 Thousand USD | -21481.533% |
| Omeros Corporation | -69.77 Million USD | 188.765% |
| Humacyte, Inc. | -76.55 Million USD | 180.913% |
| Immunocore Holdings plc | 248.39 Million USD | 75.064% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 508.326% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 0.71% |
| Blueprint Medicines Corporation | 236.58 Million USD | 73.819% |
| CalciMedica, Inc. | -58 Thousand USD | 106891.379% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 4443.548% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -113.178% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 2277.883% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 300.677% |
| Pulmatrix, Inc. | -8.22 Million USD | 853.516% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 5393.932% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 15623.559% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 115.532% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -2131.566% |
| Cytokinetics, Incorporated | -322.59 Million USD | 119.2% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -7084.624% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 18263.93% |
| Vor Biopharma Inc. | -3.49 Million USD | 1873.74% |
| Roivant Sciences Ltd. | 109.23 Million USD | 43.297% |
| Evogene Ltd. | 1.39 Million USD | -4327.377% |
| ProKidney Corp. | -3.16 Million USD | 2054.528% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 241.053% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -803.296% |
| CorMedix Inc. | -205.56 Thousand USD | 30231.542% |
| BioLineRx Ltd. | 1.1 Million USD | -5490.162% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 178.732% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 187793.939% |
| Atai Life Sciences N.V. | -5000.00 USD | 1238880.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 50928.416% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 64619.792% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 4559.251% |
| Sagimet Biosciences Inc. | 2 Million USD | -2996.95% |
| MediciNova, Inc. | 979.7 Thousand USD | -6222.209% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 173.458% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 65605.79% |
| GeoVax Labs, Inc. | -20.72 Million USD | 398.922% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 74.671% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1574.387% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 92.9% |
| Mereo BioPharma Group plc | 7.42 Million USD | -734.083% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 20080.323% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 516258.333% |
| Absci Corporation | -41.84 Million USD | 248.006% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1238880.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 181.101% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 2616.822% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 71.021% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 6682.253% |
| Allakos Inc. | -6.14 Million USD | 1108.614% |
| Imunon, Inc. | -720 Thousand USD | 8702.579% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 189.772% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 86.985% |
| BioAtla, Inc. | -103.73 Million USD | 159.711% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 543043.548% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 34897.191% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 125.508% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 20016.077% |
| XOMA Corporation | 3.86 Million USD | -1504.222% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 188.377% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -318.676% |
| aTyr Pharma, Inc. | -2.38 Million USD | 2693.76% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -397.103% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 213682.759% |
| Viridian Therapeutics, Inc. | -1 Million USD | 6244.742% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -476453746.154% |
| Akari Therapeutics, Plc | -4000.00 USD | 1548575.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 90.275% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -31711.225% |
| UroGen Pharma Ltd. | 73.35 Million USD | 15.559% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 332.033% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -533396.985% |
| Orgenesis Inc. | -5.72 Million USD | 1181.904% |
| Entera Bio Ltd. | -56 Thousand USD | 110705.357% |
| GH Research PLC | -315 Thousand USD | 19763.175% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 32871.958% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 11897.905% |
| Xencor, Inc. | -85.26 Million USD | 172.647% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 28129.614% |
| Replimune Group, Inc. | -2.65 Million USD | 2432.919% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 6286.254% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 65.172% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -31711.225% |
| Portage Biotech Inc. | -54 Thousand USD | 114801.852% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 65605.79% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 16529.443% |
| OncoCyte Corporation | 413 Thousand USD | -14897.337% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1378053.281% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 27900550.45% |
| Purple Biotech Ltd. | -196 Thousand USD | 31701.531% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -590.667% |
| scPharmaceuticals Inc. | 9.78 Million USD | -533.194% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 693.004% |
| HilleVax, Inc. | -2.15 Million USD | 2972.866% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 63954.639% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 412916.582% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 9372.305% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 269400.0% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 825275.589% |
| Savara Inc. | -44.26 Million USD | 239.937% |
| Curis, Inc. | 9.81 Million USD | -531.322% |
| Daré Bioscience, Inc. | 2.76 Million USD | -2136.451% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 49735.382% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 3682.36% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 27266.228% |
| BeiGene, Ltd. | 2.07 Billion USD | 97.021% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 2315.351% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 115.498% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -9.263% |
| Erasca, Inc. | -3.73 Million USD | 1759.673% |
| bluebird bio, Inc. | -4.03 Million USD | 1636.948% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 219601.736% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 96.748% |
| DBV Technologies S.A. | 15.72 Million USD | -293.814% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 219601.736% |
| Moderna, Inc. | 2.15 Billion USD | 97.126% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 6869.29% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -673.657% |
| Molecular Templates, Inc. | 50.39 Million USD | -22.907% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 11655.784% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 53.704% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1095.484% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 257.433% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 155.737% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 1826.282% |
| MacroGenics, Inc. | 50.52 Million USD | -22.586% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1115.726% |
| Prime Medicine, Inc. | -147.9 Million USD | 141.878% |
| Aditxt, Inc. | -111.66 Thousand USD | 55571.073% |
| Adagene Inc. | 18.11 Million USD | -241.987% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -12592.418% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 55.822% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 60.757% |
| SciSparc Ltd. | 2.19 Million USD | -2720.537% |
| Vericel Corporation | 135.57 Million USD | 54.314% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 247371.348% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 200019.308% |
| Generation Bio Co. | -73.91 Million USD | 183.802% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 14273.684% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -13.402% |
| Invivyd, Inc. | -2.02 Million USD | 3154.191% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 120.589% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 59980.315% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 35.727% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 36.982% |
| ADMA Biologics, Inc. | 88.21 Million USD | 29.789% |
| Clene Inc. | 533 Thousand USD | -11520.826% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -156.91% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 6572.205% |
| GeoVax Labs, Inc. | -20.72 Million USD | 398.922% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -3015.644% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 31975.399% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -24.363% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 973.364% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 7508.971% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 25.746% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -84617.967% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -16.51% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 135.764% |
| Trevena, Inc. | 1.45 Million USD | -4156.976% |
| Surrozen, Inc. | -27.23 Million USD | 327.466% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 17646.459% |
| Cingulate Inc. | -582.91 Thousand USD | 10725.68% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 199903.226% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 414.427% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 818316.645% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 7130.533% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 90.901% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 6369.13% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 110033.975% |
| Kronos Bio, Inc. | 1.37 Million USD | -4414.504% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 215.416% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 21311.986% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 12784.256% |
| ImmunityBio, Inc. | -17.89 Million USD | 446.221% |
| Korro Bio, Inc. | -3.63 Million USD | 1806.309% |
| Kineta, Inc. | 5.43 Million USD | -1040.052% |
| BioVie Inc. | -229.37 Thousand USD | 27103.143% |
| Codexis, Inc. | 57.33 Million USD | -8.032% |
| Celularity Inc. | 6.75 Million USD | -816.936% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1443.459% |
| Celcuity Inc. | -142.77 Thousand USD | 43483.156% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -122333.287% |
| Cibus, Inc. | 1.42 Million USD | -4255.767% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 16661.23% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 370.252% |
| IN8bio, Inc. | -2.5 Million USD | 2576.569% |
| Kodiak Sciences Inc. | -25.94 Million USD | 338.714% |
| Annexon, Inc. | -3.26 Million USD | 1995.898% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 3130.284% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 248.403% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -9577.969% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 92.044% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 64.188% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 3359.947% |
| Arcellx, Inc. | 108.27 Million USD | 42.797% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 291.353% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 21.798% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 392.828% |
| Moolec Science SA | -143.3 Thousand USD | 43321.8% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 246.366% |
| Geron Corporation | -123.5 Million USD | 150.152% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -1784.363% |
| Royalty Pharma plc | 1.79 Billion USD | 96.547% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 188.371% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 1714911.739% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -26668.111% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 155.594% |
| Humacyte, Inc. | -76.55 Million USD | 180.913% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 6625.569% |
| 89bio, Inc. | -273 Thousand USD | 22788.278% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 5027.526% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 7404.127% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 50456.911% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -5435.21% |
| Notable Labs, Ltd. | 113 Thousand USD | -54713.274% |
| Liquidia Corporation | 14.6 Million USD | -324.24% |
| Mustang Bio, Inc. | -2.22 Million USD | 2883.775% |
| Immunovant, Inc. | -231 Thousand USD | 26913.42% |
| Quantum-Si incorporated | 488 Thousand USD | -12592.418% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 211.483% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 206563.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -3226.477% |
| Acasti Pharma Inc. | -11 Thousand USD | 563181.818% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 30370.701% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 9651.796% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 136.976% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -5359.201% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 16356.955% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 3263.381% |
| PepGen Inc. | -1.18 Million USD | 5331.334% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 48870.866% |
| United Therapeutics Corporation | 2.07 Billion USD | 97.008% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 370.511% |
| Solid Biosciences Inc. | -76.56 Million USD | 180.899% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 75102.119% |
| Immuneering Corporation | -764.13 Thousand USD | 8205.735% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -93373.077% |
| Belite Bio, Inc | -399 Thousand USD | 15623.559% |
| XOMA Corporation | 3.86 Million USD | -1504.222% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 409.139% |
| Bionomics Limited | -434.44 Thousand USD | 14356.909% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 5867.132% |
| uniQure N.V. | 2.21 Million USD | -2696.343% |
| Cassava Sciences, Inc. | -89.42 Million USD | 169.265% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 167.275% |
| Forte Biosciences, Inc. | -9000.00 USD | 688311.111% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 7517.844% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 14273.684% |
| Altimmune, Inc. | -65.37 Million USD | 194.747% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 82.891% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 5867.132% |
| Compugen Ltd. | 31.45 Million USD | -96.913% |
| Peak Bio, Inc. | 367.76 Thousand USD | -16741.822% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -152.647% |
| Benitec Biopharma Inc. | 108 Thousand USD | -57250.926% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 79508.974% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 5248.712% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 3499.506% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 52149.58% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 5248.712% |
| Instil Bio, Inc. | -4.75 Million USD | 1402.334% |
| argenx SE | 1.1 Billion USD | 94.412% |
| Immunome, Inc. | -8.9 Million USD | 795.397% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 3377.196% |
| Verona Pharma plc | -679.62 Thousand USD | 9213.716% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 35493.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 2697.023% |
| CervoMed Inc. | -1.29 Million USD | 4888.011% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 2673.286% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1396.609% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -2406.637% |
| Moolec Science SA | -143.3 Thousand USD | 43321.8% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 15280.011% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 2418.486% |
| AnaptysBio, Inc. | 14.78 Million USD | -319.045% |
| Design Therapeutics, Inc. | -537 Thousand USD | 11634.264% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 14605.621% |
| NeurAxis, Inc. | 2.15 Million USD | -2771.929% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -2786.253% |
| Lumos Pharma, Inc. | 2 Million USD | -2986.148% |
| Achilles Therapeutics plc | -4.73 Million USD | 1409.142% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 35493.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 58712.728% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -95.646% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -7084.624% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 6101.841% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 235.986% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -143944.186% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 7635.158% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 470832.634% |
| Palisade Bio, Inc. | 246 Thousand USD | -25078.455% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 187793.939% |
| Beam Therapeutics Inc. | -59.67 Million USD | 203.799% |
| Neurogene Inc. | -3.26 Million USD | 1998.804% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 55.547% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 1777.654% |
| Sesen Bio, Inc. | 40 Million USD | -54.848% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 20954.882% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 1638.079% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 747.491% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -339.908% |
| Athira Pharma, Inc. | -969 Thousand USD | 6492.054% |
| Vaccinex, Inc. | -16 Million USD | 487.022% |
| HCW Biologics Inc. | -574.82 Thousand USD | 10875.298% |
| XOMA Corporation | 3.86 Million USD | -1504.222% |
| Nektar Therapeutics | 53.47 Million USD | -15.821% |
| Arvinas, Inc. | 71.8 Million USD | 13.734% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 174.213% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 198.668% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 19335.714% |
| Rezolute, Inc. | -36 Thousand USD | 172152.778% |
| Clene Inc. | 533 Thousand USD | -11520.826% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 4824009.657% |
| BeyondSpring Inc. | 1.75 Million USD | -3437.35% |
| Synlogic, Inc. | -1.92 Million USD | 3319.283% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 167502.703% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1078.19% |
| Peak Bio, Inc. | 367.76 Thousand USD | -16741.822% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 426.631% |
| Krystal Biotech, Inc. | 47.6 Million USD | -30.11% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 56.1% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1132.617% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 2492.189% |
| MannKind Corporation | 136.19 Million USD | 54.52% |
| Ikena Oncology, Inc. | -50.49 Million USD | 222.671% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 43.078% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1512.52% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 24678.968% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1238880.0% |
| Legend Biotech Corporation | 140.92 Million USD | 56.05% |
| Mural Oncology plc | -2.56 Million USD | 2512.894% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 11341.198% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 62039.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -198.444% |
| REGENXBIO Inc. | 53.02 Million USD | -16.802% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1256.236% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 32297.011% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 3676.155% |
| Vaxart, Inc. | -60.76 Million USD | 201.935% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 23670.667% |
| Cellectis S.A. | 18 Thousand USD | -344005.556% |
| Longeveron Inc. | 221 Thousand USD | -27926.697% |
| Repare Therapeutics Inc. | -80.07 Million USD | 177.356% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 94.333% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 4886.631% |
| Revolution Medicines, Inc. | -399.66 Million USD | 115.498% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 177068.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -126306.122% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.28% |
| Denali Therapeutics Inc. | -93.34 Million USD | 166.355% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 247371.348% |
| Veru Inc. | 7.56 Million USD | -718.657% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 41119.205% |
| Cingulate Inc. | -582.91 Thousand USD | 10725.68% |
| Passage Bio, Inc. | -3.72 Million USD | 1764.579% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 514372.667% |
| Exicure, Inc. | -1.42 Million USD | 4452.706% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 16272.063% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -2191.491% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 12181.533% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 9.082% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 41501.138% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 204.616% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -15741.176% |
| OmniAb, Inc. | 14.66 Million USD | -322.302% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -209.803% |
| Lipocine Inc. | -2.85 Million USD | 2272.675% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 3460.77% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1185.697% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 4212.021% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 17.761% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 95390.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 26.522% |
| Ocugen, Inc. | -33.53 Million USD | 284.689% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 2058.855% |
| Q32 Bio Inc. | 578 Thousand USD | -10616.09% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 23473.208% |
| Alumis Inc. Common Stock | -1.28 Million USD | 4923.91% |
| Equillium, Inc. | 35.95 Million USD | -72.254% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 3728.53% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -12271.0% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1498382.535% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 24014.672% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -14552.766% |
| Dominari Holdings Inc. | 2.03 Million USD | -2937.715% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 33859.559% |
| vTv Therapeutics Inc. | -13.59 Million USD | 555.601% |
| Bio-Techne Corporation | 773.07 Million USD | 91.988% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -257.636% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 86.558% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 5398.46% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 358.294% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -429.529% |
| Nkarta, Inc. | -5.86 Million USD | 1155.359% |
| BioCardia, Inc. | -7.24 Million USD | 954.449% |
| Iterum Therapeutics plc | -1.75 Million USD | 3639.371% |